Skip to main content
. 2017 Jun;102(6):1035–1043. doi: 10.3324/haematol.2017.163964

Figure 3.

Figure 3.

Overall survival (OS). Kaplan-Meier estimates of OS depending on comparisons between patients with mast cell leukemia (MCL, n=28) and a control group of patients with advanced systemic mastocytosis (without MCL) (n=124) enrolled within the ‘German Registry on Disorders of Eosinophils and Mast Cells’. CI: confidence interval; HR: hazard ratio.